New Procedure Improved Limb Salvage in Ischemia Trial
For patients ineligible for traditional surgery, a new deep vein treatment helped preserve limbs and reduce chronic pain.
Updated on Oct. 12, 2026 in Heart Disease
Live Poll
Do you trust that experimental surgical techniques are safe for patients with chronic health conditions?
The PROMISE III trial found that transcatheter arterialization of the deep veins successfully saved limbs in patients with chronic limb-threatening ischemia. This procedure offers a potential alternative for individuals who are otherwise ineligible for standard surgical or endovascular revascularization.
Why it matters
Chronic limb-threatening ischemia often leads to amputation when conventional repair is not possible. This technique provides a new option to improve blood flow, reduce severe pain, and help patients maintain mobility when other treatments have been ruled out.
In the PROMISE III trial of 100 patients, the procedure achieved a 97% technical success rate. At 1 year, the cohort demonstrated an 84.1% limb salvage rate and a 76.3% amputation-free survival rate, with mean pain scores dropping from 6 at baseline to 0.
The players
PROMISE III trial
A clinical study investigating transcatheter arterialization of deep veins for chronic limb-threatening ischemia.
The details
The procedure works by diverting blood flow through arterialization of the foot's deep veins. By leveraging healthier leg veins as conduits, the technique delivers oxygenated blood to distal venous tissue that is otherwise deprived. This bypasses blockages that standard surgeries cannot address, helping to heal wounds and reduce tissue death in patients, including those with comorbidities like dialysis needs.
Timeline
At 3 months, 5% of patients had fully healed wounds.
At 6 months, 34% of patients had fully healed wounds.
At 1 year, 64% of patients had fully healed wounds.
Health Landscape
The PROMISE III trial establishes a new benchmark for limb salvage in patients deemed ineligible for traditional surgery. This development represents a shift in the treatment landscape, offering a viable interventional path where the standard of care was historically limited.
If you or a loved one are facing limb-threatening ischemia without traditional surgical options, this procedure is worth discussing with a vascular specialist. Pay close attention to wound healing progress and consult your doctor to see if you meet the specific clinical criteria for this approach.
The takeaway
This trial shows that a minimally invasive vein-arterialization technique can significantly reduce chronic pain and salvage limbs in complex cases. Patients should prioritize consistent wound monitoring and reach out to a specialized center to review all available revascularization options.
Further reading
For more on managing vascular health, explore our latest Heart Disease insights.
Source note: This article includes information reported by Tctmd.
Live Poll
Do you trust that experimental surgical techniques are safe for patients with chronic health conditions?
